A Phase II of Rituximab in Myasthenia Gravis (NN 103)

Grant

Awarded By

Total Award Amount

  • 16536.00

    • Direct Costs

  • 11249.00

    • Sponsor Award Id

    • Contributor

  • Eroboghene Ubogu   Investigator